From Malaria to Worms  by unknown
Chemistry & Biology
SelectFromMalaria to Worms
Each month, Chemistry & Biology Select highlights a selection of research reports recently
published in other journals. These highlights are a snapshot of interesting research done across
the field of chemical biology and this month’s Select features a new study of Plasmodium
N-myristoyltransferase (NMT), a discovery of an alternative cation conducting pathway in a TRP
channel, TRPM3, a structural and functional analysis of d-opioid receptor, and identification of
new ligands for DAF-12, a nuclear hormone receptor in C. elegans.The two classes of malaria parasite NMT inhibi-
tors identified by the authors share major bind-
ing determinants but traverse the binding site
by different trajectories. Image courtesy of
E. Tate, M.D. Rackham, and J.A. Brannigan.New Strategy for Defeating Malaria
Malaria, a disease caused by Plasmodium parasites, continues to be a serious
health and societal burden in developing countries. Although there are number
of treatment options for malaria, resistance to these treatments has been
emerging, highlighting the need to identify new viable drug targets. One
such target is the Plasmodium N-myristoyltransferase (NMT). NMTs catalyze
transfer of myristate (Myr) from Myr-CoA to substrate proteins and are found
in all eukaryotes. Members of Plasmodium genus express a single NMT
enzyme that was previously proposed to be a potential drug target. However,
questions about Plasmodium NMT function, the nature and number of its
substrates, and the effect of NMT inhibition on the parasite physiology are
wide open.
A recent report by Wright et al. (2013) significantly changes this situation.
The authors combine chemical proteomic profiling, small molecule inhibitor
development, biochemical and structural analysis, and testing using intraery-
throcytic parasite cultures and an in vivo rodent model to provide answers to
those questions. They identify more than 30 NMT substrates with a range of
functions, including motility, invasiveness, and development. Additionally,
the authors show that the two small molecules they developed lead to killing
of blood-stage parasites via NMT inhibition in parasite cultures and that one
of the small molecules exhibits promising in vivo activity in the mouse model.
Furthermore, Wright et al. provide evidence that NMT inhibition prevents the
innermembrane complex (IMC) assembly in asexual blood-stage parasites,
thus contributing to parasite death. Overall, this work has important implications for studying NMT function and the role of
N-myristoylation in Plasmodium and highlights opportunities for future antimalarial drug development.
Wright, M.H., et al. (2014) Nat. Chem. 6, 112–121.An Alternate Route in the TRP Channel
Transient receptor potential (TRP) channels are a family of ion channels with diverse physiological roles, from sensing pain to
sensing wasabi. TRP channels share the basic tetramer architecture and gating and conduction mechanisms with a larger
superfamily of cation channels. Recently, evidence emerged that cation channels baring specific mutations have an alterna-
tive route for cations to use, distinct from the central cation-conducting pore.
Vriens et al. report that such an alternative pathway exists and functions in a TRP channel, TRPM3, which, among other
things, plays a role in aversive and nocifensive behavior responses to neurosteroid pregnenolone sulfate (PS). First, the
authors saw that combined use of PS and an antifungal drug, clotrimazole (Clt), leads to significant potentiation of TRPM3
currents. Interestingly, when Clt was applied at a concentration of 1 mM or higher, the authors noticed significant inwardly
rectifying current under strongly hyperpolarizing potentials. After ruling out that the effect might be due to Clt-induced
change of channel selectivity or through indirect effects, the researchers focus on providing evidence for the existence of
alternative permeation pathway. Vriens et al. show that Clt leads to the change in PS-induced cation influx by promoting
Na+ influx over Ca2+, that blocking the outward current does not inhibit the inward one, and that two distinct types of currents
are seen at the single channel level, which all suggests that inwardly rectifying current uses a path different from the
central cation-conducting pore. Additional mutagenesis-based analysis and measurements in sensory neurons further
support this conclusion. Importantly, in vivo tests done in mice point to the possibility that Clt-induced alternative cation
pathway results in enhanced pain response to PS. Thismay have implications for themolecular basis of knownClt side effects
and points to the possibility that an alternative cation route might exist in other TRP channels.
Vriens et al. (2014). Nat. Chem. Biol. Published online January 5, 2014. http://dx.doi.org/10.1038/nchembio.1428.Chemistry & Biology 21, February 20, 2014 ª2014 Elsevier Ltd All rights reserved 165
The 1.8 A˚ resolution structure of the d-opioid
receptor (grey cartoon) showing the sodium
ion (blue sphere) and some of the ‘‘efficacy
switch’’ residues (orange sticks) in the
receptor allosteric site. Smaller red spheres
are waters in the first and second coor-
dination shells of the sodium ion. The
morphinan derivative ligand naltrindole is
represented by yellow sticks. The chemical
structure of morphine is also shown. Image
courtesy of Katya Kadyshevskaya in the
R.C. Stevens lab at The Scripps Research
Institute.
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Opioid receptors (OR) are members of the G protein-coupled receptor (GPCR)
family that respond to endogenous and exogenous opioid ligands, as well as a
growing number of small molecule agonists. It is known that agonists exert their
effect on ORs by binding to an orthosteric site, although mechanistic details at a
molecular level are still unclear.
In a recent study, Fenalti et al. describe a high-resolution crystal structure of the
human d-OR in complex with naltrindole, a selective d-OR anatagonist, which led
to the discovery of an unexpected allosteric Na+ site. To facilitate crystallization,
the authors used a carefully prepared construct in which segments of the N and
C termini of human d-OR were removed and the thermostabilized E. coli apocyto-
chrome b562RIL (BRIL) fused to the truncated N terminus. The resulting construct
crystallized from the lipid cubic phase and diffracted to 1.8 A˚ resolution. The con-
struct’s organization and the improved resolution over the available structure of
mouse d-OR fused to T4 lysozyme enabled a clearer view of the intracellular
loop 3, the orthosteric binding pocket, and the previously mentioned allosteric
Na+ site to emerge. Interestingly, the structure captures d-OR in inactive state
conformation in which the Na+ ion forms a connectivity network that involves
both d-OR residues and a number of water molecules and likely serves to enable
communication between orthosteric and allosteric sites. Follow-up studies using
point mutations of Na+ site residues show that allosteric Na+ anchoring residues
act as efficacy switches and redirect d-OR signaling from the Gai protein pathway
to a noncanonical b-arrestin pathway. This has interesting implications for d-OR
signaling, physiology, and pharmacology.
Fenalti et al. (2014). Nature. Published online January 12, 2014. http://dx.doi.org/
10.1038/nature12944.New Ligands for DAF-12
Nuclear hormone receptors (NHRs) are transcription factors regulated by small
molecules, for example steroid hormones. They orchestrate expression of large
number of genes to control diverse cellular processes such as development andaging. In simple terms, ligand binding leads to conformational change that modulates NHR interaction with co-activator
and co-repressor proteins and leading to specific changes in transcription of target genes. Some NHRs bind more than
one ligand, and different ligands are known to elicit different responses. Unfortunately, our current map of the entire NHR
ligand space contains significant gaps, even in well studied models such as C. elegans or mouse.
The recent efforts of Mahanti et al. are aimed at filling out some of these gaps and identifying additional ligands for the most
prominent NHR in C. elegans, DAF-12. The authors combine an NMR-based metabolomics strategy, DANS (differential
analyses by 2D NMR spectroscopy), which provides an unbiased view of the metabolome, with specific genetic manipulation
of C. elegans, which introduces defined perturbations in the biosynthetic pathway known to produce DAF-12 ligands.
Comparison between wild-type and mutant metabolomes led to identification of several steroid molecules with unusual
structures: (25S)-3-oxo-1,7-cholestadienoic acid, (25S)-3-oxo-7-cholestenoic acid, and (25S)-3a-hydroxy-7-cholestenoic
acid. The authors show that these metabolites are DAF-12 ligands and that they act through DAF-12 to regulate develop-
mental progression and C. elegans lifespan. Additionally, Mahanti et al. examine biosynthesis of DAF-12 ligands and show
that it is tissue-specific and that ligands may be produced by nonidentical pathways and at different levels at different life
stages. This work highlights the diversity of NHR ligand chemical space and the need to use sophisticated analytical methods
to reinvestigate mammalian NHR ligand biosynthesis and NHR physiology, which play major roles in regulating human
development and metabolism.
Mahanti et al. (2014). Cell Met. 19, 73–83.
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